# Development of an EEG Diagnostic for Alzheimer's Disease

> **NCT04954183** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 29 (actual)

## Conditions studied

- Mild Cognitive Impairment
- Alzheimer Disease
- Dementia With Lewy Bodies
- Normal Control APOE e4 Carriers and Noncarriers

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04954183
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2025-07-24
- **Final completion:** 2025-07-24
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2025-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04954183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04954183, "Development of an EEG Diagnostic for Alzheimer's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04954183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*